β-amino alcohols as promising inhibitory candidates against the SARS-CoV-2, A theoretical design based on MD simulation and DFT insights

被引:0
|
作者
Eshghi, Hossein [1 ]
Noroozi-Shad, Nazanin [1 ]
Seddighi, Mohammad Javad [1 ]
Sabet-Sarvestani, Hossein [1 ]
机构
[1] Ferdowsi Univ Mashhad, Fac Sci, Dept Chem, Mashhad, Iran
关键词
Chiral n -amino alcohols; Main-Protease of COVID-19; Molecular docking; DFT insights; Molecular Dynamics Simulation; MOLECULAR-DYNAMICS SIMULATIONS; FREE-ENERGY LANDSCAPES; MAIN PROTEASE; CORONAVIRUS; DOCKING; DERIVATIVES; NELFINAVIR; PROTEINS; MOTIONS;
D O I
10.1016/j.comptc.2024.114872
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Nelfinavir, as a compound with a Chiral n-amino alcohol unit, is a well-known inhibitor against HIV-protease, studying. The role of heterocyclic derivatives of Nelfinavir as inhibitors against the Main-Protease of COVID19 is the main purpose of this study. To reach a deep understanding, different theoretical approaches including molecular docking, Molecular Dynamic (MD) simulations, and DFT insights are applied in the studies. Investigation of the ligand bioactivity reveals that smaller HOMO/LUMO band gaps and lower chemical hardness (eta), mean stronger interaction with the active site of the Main-Protease for the corresponding n-amino alcohols. Analyzing the efficient interactions in binding energy shows that among the studied Chiral n-amino alcohols, formed Van der Waals interactions via it and alkyl parts of ligands have more remarkable roles in inhibitory effects than hydrogen bonding. Accordingly, molecular mechanics (MM) and polar interactions have the highest contributions to the total energy of residues. Finally, it has been concluded that among the studied derivatives those that contain Dihydroisoquinoline (4b), and Perhydroisoquinoline (4d) heterocyclic rings can be considered as more potent candidates against Main-Protease of COVID-19.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Identification of promising drug candidates against NSP16 of SARS-CoV-2 through computational drug repurposing study
    Vijayan, Viswanathan
    Pant, Pradeep
    Vikram, Naval
    Kaur, Punit
    Singh, T. P.
    Sharma, Sujata
    Sharma, Pradeep
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (17): : 6713 - 6727
  • [32] Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro
    Jo, Seri
    Kim, Suwon
    Kim, Dae Yong
    Kim, Mi-Sun
    Shin, Dong Hae
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) : 1539 - 1544
  • [33] Structure-based design and characterization of novel fusion-inhibitory lipopeptides against SARS-CoV-2 and emerging variants
    Yu, Danwei
    Zhu, Yuanmei
    Jiao, Tao
    Wu, Tong
    Xiao, Xia
    Qin, Bo
    Chong, Huihui
    Lei, Xiaobo
    Ren, Lili
    Cui, Sheng
    Wang, Jianwei
    He, Yuxian
    EMERGING MICROBES & INFECTIONS, 2021, 10 (01) : 1227 - 1240
  • [34] Antiviral Properties of Alginate-Based Biomaterials: Promising Antiviral Agents against SARS-CoV-2
    Serrano-Aroca, Angel
    Ferrandis-Montesinos, Maria
    Wang, Ruibing
    ACS APPLIED BIO MATERIALS, 2021, 4 (08) : 5897 - 5907
  • [35] Deep learning-based molecular dynamics simulation for structure-based drug design against SARS-CoV-2
    Sun, Yao
    Jiao, Yanqi
    Shi, Chengcheng
    Zhang, Yang
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2022, 20 : 5014 - 5027
  • [36] Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
    Shehzadi, Kiran
    Saba, Afsheen
    Yu, Mingjia
    Liang, Jianhua
    TOPICS IN CURRENT CHEMISTRY, 2023, 381 (05)
  • [37] Structure-Based Drug Design of RdRp Inhibitors against SARS-CoV-2
    Kiran Shehzadi
    Afsheen Saba
    Mingjia Yu
    Jianhua Liang
    Topics in Current Chemistry, 2023, 381
  • [38] A Review on Screening Models for Potential Therapeutic Candidates and Targets Against SARS-CoV-2
    Das, Mohana
    Kumar, Manish
    Jha, Abhishek
    Madhukiran, D. R.
    Bharti, Kanchan
    Mondal, Shomedeep
    Mishra, Brahmeshwar
    CURRENT DRUG TARGETS, 2021, 22 (11) : 1232 - 1254
  • [39] Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
    Dai, Wenhao
    Zhang, Bing
    Jiang, Xia-Ming
    Su, Haixia
    Li, Jian
    Zhao, Yao
    Xie, Xiong
    Jin, Zhenming
    Peng, Jingjing
    Liu, Fengjiang
    Li, Chunpu
    Li, You
    Bai, Fang
    Wang, Haofeng
    Cheng, Xi
    Cen, Xiaobo
    Hu, Shulei
    Yang, Xiuna
    Wang, Jiang
    Liu, Xiang
    Xiao, Gengfu
    Jiang, Hualiang
    Rao, Zihe
    Zhang, Lei-Ke
    Xu, Yechun
    Yang, Haitao
    Liu, Hong
    SCIENCE, 2020, 368 (6497) : 1331 - +
  • [40] MD simulation and MM/PBSA identifies phytochemicals as bifunctional inhibitors of SARS-CoV-2
    Sharma, Monica
    Mahto, Jai Krishna
    Dhaka, Preeti
    Neetu, Neetu
    Tomar, Shailly
    Kumar, Pravindra
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2022, 40 (22): : 12048 - 12061